The UK’s leading firm of independent costs lawyers

Abbott v Ministry of Defence- The Costs Consequences of a Landmark Military NIHL Decision. Written by Nick McDonnell.

Abbott v Ministry of Defence: The Costs Consequences of a Landmark Military NIHL Decision

Posted

The High Court decision in Abbott v Ministry of Defence is already being discussed as one of the most significant military noise-induced hearing loss (“M-NIHL”) judgments in recent years. Much of the immediate commentary has understandably focused on the medical and evidential implications of the case: revised diagnostic models, de minimis hearing loss, audiological methodology, and the court’s cautious treatment of emerging scientific theories.

However, while Abbott is primarily a substantive liability and quantum decision, its long-term impact may extend well beyond causation evidence and into the economics of litigation itself. For costs professional, litigation funders, medico-legal agencies, claimant firms and defendant insurers, the judgment may prove to be equally important as a costs and proportionality case as it is a clinical one.

The military deafness litigation sector has, for many years, operated as a form of industrial-scale group litigation. Thousands of claims have been investigated and pursued through portfolio management models involving standardised evidence, repeat experts, matrix settlements and economies of scale. Abbott has the potential to reshape that landscape significantly.

Greater Emphasis on Proportionality

Perhaps the clearest costs implication arising from Abbott is the likely increase in proportionality challenges.

The judgment appears to draw a firmer line around low-level or marginal hearing loss claims. In particular, the court’s treatment of de minimis loss may embolden defendants to argue that claims involving minimal measurable damage should either never have been litigated or should have been resolved at a much earlier stage.

That matters because proportionality under CPR 44 is not assessed purely by reference to whether costs were reasonably incurred. The court must also consider whether the overall costs bear a reasonable relationship to the value, complexity and importance of the claim.

In practice, this creates obvious tension within military NIHL litigation. Many claims require extensive evidence gathering, including service records, occupational histories, audiograms, expert screening reports and detailed causation evidence. Yet if damages are ultimately modest, or if the hearing loss falls close to the de minimis threshold identified in Abbott, defendants are likely to argue that substantial litigation costs are disproportionate to the outcome achieved.

This may particularly affect claims where:

  • damages settle at relatively low levels;
  • tinnitus claims are weak or unsupported;
  • hearing aid recommendations are not pursued;
  • multiple experts are instructed;
  • or causation arguments rely upon scientific theories treated cautiously by the High Court.

Costs lawyers should therefore expect to see Abbott cited not merely in substantive proceedings, but increasingly within Points of Dispute, Replies, and detailed assessment hearings.

Expert Fees Under Increased Scrutiny

One of the most immediate battlegrounds following Abbott is likely to concern expert evidence and the recoverability of associated fees.

The judgment devotes considerable attention to competing audiological methodologies and to the reliability of differing approaches to diagnosing military NIHL. That inevitably creates downstream costs consequences.

Defendants are likely to argue that expert evidence founded upon theories rejected, criticised or treated cautiously within Abbott was not reasonably incurred. Claimant firms may find themselves defending:

  • the choice of expert;
  • the necessity for supplemental reports;
  • conference fees;
  • joint statements;
  • updated audiological testing;
  • and the recoverability of reports obtained before the legal position became clearer.

The issue is not simply whether an expert was “reasonable” at the time of instruction. The more difficult question may become whether the scope and scale of expert evidence remained proportionate once weaknesses in particular methodologies became apparent.

This may also create renewed debate concerning the recoverability of screening reports and bulk medical evidence obtained during high-volume acquisition exercises. Where firms pursued large inventories of claims using standardised medical processes, defendants may increasingly seek to distinguish between genuinely case-specific evidence and evidence generated primarily to support portfolio litigation models.

For costs lawyers acting for claimant firms, detailed attendance notes and careful justification of expert decisions are likely to become increasingly important. The days of assuming that all audiology evidence will pass without challenge may be coming to an end.

Pressure on the Economics of Volume Litigation

The military deafness sector has, historically, relied upon volume.

Like many industrial disease practice areas, profitability has often depended less upon the value of individual claims and more upon the efficient management of large numbers of similar files. Standardised workflows, repeat experts and matrix settlements have allowed firms to operate claims economically despite relatively modest average damages.

Abbott may place pressure on that model.

If the judgment results in:

  • lower average settlements;
  • increased claim failures;
  • greater evidential disputes;
  • or heightened scrutiny of expert evidence,

then margins within the sector may tighten considerably.

This has important implications for costs recovery. Firms operating under Conditional Fee Agreements may face greater irrecoverable expenditure, particularly where claims are abandoned following updated medical review or where experts recommend discontinuance after Abbott-style scrutiny is applied.

In practical terms, some firms may need to reassess:

  • acquisition strategies;
  • medical screening thresholds;
  • case selection criteria;
  • and the commercial viability of lower-value claims.

Costs professionals may therefore become involved earlier in the lifecycle of these cases, assisting firms not simply with recovery after conclusion, but with strategic decisions concerning proportionality and risk at the outset.

Detailed Assessment Litigation is Likely to Increase

Paradoxically, a judgment intended to provide clarity may generate further satellite litigation.

Whenever courts redefine evidential standards within a specialist litigation field, costs disputes tend to follow. Abbott is unlikely to be an exception.

Defendants now possess a detailed High Court authority which can be deployed to challenge:

  • the necessity of certain medical disciplines;
  • the reasonableness of pursuing marginal claims;
  • the proportionality of prolonged litigation;
  • and the recoverability of work associated with abandoned scientific arguments.

This may lead to increasingly technical detailed assessments in which judges are asked to consider not only costs law principles, but also the underlying audiological science.

We may therefore see more disputes concerning:

  • whether additional reports were truly necessary;
  • whether litigation should have settled earlier;
  • whether particular causation arguments were realistically sustainable;
  • and whether certain work represented legitimate claim preparation or merely speculative investigation.

For specialist costs lawyers, this creates both challenge and opportunity. Those with a detailed understanding of NIHL litigation, military exposure evidence and expert methodology are likely to become increasingly valuable.

Conduct Arguments and Early Discontinuance

Abbott may also increase conduct-based costs arguments.

Where claims continue despite weak audiological evidence or marginal measurable loss, defendants may argue that proceedings should have been discontinued earlier. That could lead to more frequent reliance upon CPR 44.11 or broader unreasonable conduct arguments during detailed assessment.

Claimant firms will therefore need robust internal review procedures. It is likely to become increasingly important to demonstrate:

  • ongoing merits assessment;
  • periodic expert review;
  • reconsideration of causation evidence;
  • and active decision-making throughout the litigation process.

This is particularly important in volume litigation environments, where the risk always exists that cases continue progressing through standardised systems without sufficient individual scrutiny.

Defendants may seek to characterise such cases as examples of industrialised litigation lacking adequate case-specific analysis. Whether that argument ultimately succeeds remains uncertain, but Abbott provides defendants with additional material to support it.

Impact on Settlement Strategy

The decision may also influence how military deafness claims settle.

Historically, many military NIHL cases have resolved through negotiated matrices or portfolio settlement structures. Such arrangements allowed parties to avoid the substantial costs and risks associated with litigating large numbers of technically complex claims individually.

Abbott may accelerate that trend.

Both claimant and defendant representatives may now have greater incentive to develop:

  • revised settlement bands;
  • fixed evidential assumptions;
  • streamlined expert protocols;
  • and staged medical review procedures.

The economics are obvious. If substantive disputes become more technical and more expensive, commercial pressure to avoid fully contested litigation increases correspondingly.

That could create new roles for costs specialists in advising upon:

  • portfolio settlement models;
  • allocation of common costs;
  • proportionality analysis across grouped claims;
  • and the drafting of bespoke costs provisions within matrix agreements.

In many respects, the future of military NIHL litigation may depend less upon courtroom battles and more upon the ability of parties to manage litigation risk commercially.

Wider Implications Beyond Military Claims

Although Abbott arises from military hearing loss litigation, its influence may extend into wider occupational deafness claims.

Defendants in non-military NIHL litigation are almost certain to rely upon the judgment where relevant. If courts begin adopting similar reasoning concerning de minimis loss, causation methodology or evidential reliability across broader industrial disease litigation, the costs consequences could be substantial.

That may affect:

  • factory noise claims;
  • engineering and manufacturing cases;
  • construction-related hearing loss claims;
  • and long-tail industrial disease litigation generally.

Any reduction in average claim values combined with increased evidential scrutiny creates inevitable pressure upon recoverable costs. The tension between modest damages and substantial litigation expenditure is not unique to military claims; Abbott may simply bring that issue into sharper focus. For the legal costs industry, the judgment therefore matters not only because of its direct effect upon military litigation, but because it may signal a broader judicial approach to proportionality and evidential discipline within industrial disease work.

A Changing Market

Ultimately, Abbott may become as important economically as it is legally.

The military deafness sector supports a substantial ecosystem involving claimant firms, defendant insurers, barristers, experts, medico-legal agencies, ATE providers and specialist costs professionals. Any judgment capable of reshaping claim viability will inevitably affect that wider market.

Some firms may narrow their intake criteria. Others may invest more heavily in early medical screening and merits assessment. Defendant teams may become more aggressive in challenging expert costs and proportionality. Detailed assessments may become more technical and more heavily contested.

For costs lawyers, this is unlikely to reduce work. If anything, it may increase the importance of specialist costs expertise within industrial disease litigation.

The central question after Abbott is no longer simply whether hearing loss can be proven. Increasingly, it may become whether the costs of proving it are proportionate, recoverable and commercially sustainable. That is where the real long-term significance of the case for the legal costs industry may ultimately lie.

How Kain Knight Can Help

For receiving parties, the post-Abbott landscape is likely to demand increasingly sophisticated costs strategy and technical expertise. Challenges to proportionality, expert-fee recoverability and conduct are expected to become more frequent and more detailed, particularly within military and wider NIHL litigation. Kain Knight has extensive experience acting for receiving parties in complex and high-volume litigation, including industrial disease and technically contested claims. The firm’s specialist costs lawyers and draftsman are well placed to assist claimant representatives with costs recovery strategy, detailed assessment proceedings, budgeting, settlement advice and the management of proportionality risks arising from the evolving post-Abbott litigation environment.